Radiofrequency ablation effective in treating small kidney tumors

Computed tomography-guided radiofrequency ablation was nearly 100% successful in eradicating small, malignant kidney tumors in a study of more than 100 patients, according to researchers at Wake Forest University Baptist Medical Center, Winston-Salem, NC.

Computed tomography-guided radiofrequency ablation was nearly 100% successful in eradicating small, malignant kidney tumors in a study of more than 100 patients, according to researchers at Wake Forest University Baptist Medical Center, Winston-Salem, NC.

A total of 125 tumors ranging in size from 0.6 cm to 8.8 cm in 104 patients were treated at that institution between 2000 and 2006. Of 95 tumors that were smaller than 3.7 cm, all were completely eradicated by a single treatment. In addition, 14 of the larger tumors were destroyed. Seven more of the 16 remaining larger tumors were eradicated after a second treatment, for a 93% overall success rate in the 125 tumors.

The results, reported in the American Journal of Roentgenology (2007; 189:429-36), were based on follow-up exams over an average of about 14 months.

“This is the largest treatment group to date of patients with biopsy-proven renal malignancies,” said lead author Ronald J. Zagoria, MD. “The results-a high cure rate and low complication rate-establish that at institutions with experience doing this procedure, this is an alternative method for treating small renal malignancies in patients who are not good surgical candidates.”

Related Videos
Dr. Smita De in an interview with Urology Times
Doctor receiving patient in office | Image Credit © Africa Studio - stock.adobe.com
Alisa J. Stephens-Shields, PhD, answers a question during a Zoom video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Dr. David Sheyn in an interview with Urology Times
Avinash Maganty, MD, answers a question during a Zoom video interview
blur image background of corridor in hospital or clinic image | Image Credit:  © whyframeshot - stock.adobe.com
Rachel Pope, MD, MPH, answers a question during a Zoom interview
blur image background of corridor in hospital or clinic image | Image credit: © whyframeshot - stock.adobe.com
Dr. David Canes in an interview with Urology Times
Related Content
© 2023 MJH Life Sciences

All rights reserved.